Justin Keywood

Work Performance Price Targets & Ratings Chart

Analyst Justin Keywood, currently employed at STIFEL,

Most recent stock forecast was given on MEDXF, Medexus Pharmaceuticals at 10-May-2025.

Wall Street Analyst Justin Keywood

Analyst best performing recommendations are on MEDXF (MEDEXUS PHARMACEUTICALS).

MEDXF Medexus Pharmaceuticals QIPT Quipt Home Medical Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Show more analysts